Title : Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.

Pub. Date : 2020 Feb 4

PMID : 32009527






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Methods and Results The effects of ASA on CD40L-treated human platelets, in response to suboptimal concentrations of collagen or thrombin, were assessed at levels of aggregation, thromboxane A2 secretion, and phosphorylation of p38 mitogen-activated protein kinase, nuclear factor kappa B, transforming growth factor-beta-activated kinase 1, and myosin light chain. Aspirin coagulation factor II, thrombin Homo sapiens
2 sCD40L significantly elevated thromboxane A2 secretion in platelets in response to suboptimal doses of collagen and thrombin, which was reversed by ASA. Aspirin coagulation factor II, thrombin Homo sapiens
3 sCD40L potentiated platelet aggregation, an effect completely reversed and partially reduced by ASA in response to a suboptimal dose of collagen and thrombin, respectively. Aspirin coagulation factor II, thrombin Homo sapiens